The content is available as a PDF (415.8 KB).
letter . 2020 Aug 6:hvaa193. doi: 10.1093/clinchem/hvaa193
Evaluation of Three Commercial Automated Assays for the Detection of anti-SARS-CoV-2 Antibodies
Roa Harb
h1,✉, Alan T Remaley
h2, David B Sacks
h1
Roa Harb
h1Department of Laboratory Medicine, National Institutes of Health, Bethesda, MD
Find articles by Roa Harb
Alan T Remaley
h2National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
Find articles by Alan T Remaley
David B Sacks
h1Department of Laboratory Medicine, National Institutes of Health, Bethesda, MD
Find articles by David B Sacks
h1Department of Laboratory Medicine, National Institutes of Health, Bethesda, MD
h2National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
✉
Corresponding author: Name: Roa Harb, Email: roa.harb@nih.gov, Telephone: 301-402-9795
Received 2020 Jun 29; Revised 2020 Jul 19; Accepted 2020 Jul 20.
Keywords: COVID-19, Serology, Antibodies, SARS-CoV-2
Published by Oxford University Press on behalf of the American Association for Clinical Chemistry 2020.
This work is written by (a) US Government employee(s) and is in the public domain in the US.
This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
PMCID: PMC7454464 PMID: 32761081